UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| 1 |
Alibaba
BABA
|
+$624M |
| 2 |
Microsoft
MSFT
|
+$360M |
| 3 |
Accenture
ACN
|
+$249M |
| 4 |
Walmart
WMT
|
+$205M |
| 5 |
Mastercard
MA
|
+$198M |
Top Sells
| 1 |
Vanguard Total Stock Market ETF
VTI
|
+$329M |
| 2 |
CELG
Celgene Corp
CELG
|
+$293M |
| 3 |
iShares Core MSCI EAFE ETF
IEFA
|
+$220M |
| 4 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$188M |
| 5 |
JPMorgan Chase
JPM
|
+$173M |
Sector Composition
| 1 | Technology | 19.83% |
| 2 | Financials | 14.05% |
| 3 | Healthcare | 13.56% |
| 4 | Consumer Discretionary | 12.64% |
| 5 | Communication Services | 8.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2051
Inspire Medical Systems
INSP
$2.45B
| $680K | ﹤0.01% |
9,168
+5,644
| +160% | +$419K |
|
2052
Bandwidth Inc
BAND
$494M
| $679K | ﹤0.01% |
10,598
+776
| +8% | +$49.7K |
|
2053
Evolent Health
EVH
$1.08B
| $677K | ﹤0.01% |
74,808
-516
| -0.7% | -$4.67K |
|
2054
RE/MAX Holdings
RMAX
$199M
| $669K | ﹤0.01% |
17,378
-3,421
| -16% | -$132K |
|
2055
Movado Group
MOV
$441M
| $668K | ﹤0.01% |
30,720
+9,943
| +48% | +$216K |
|
2056
Levi Strauss
LEVI
$8.74B
| $664K | ﹤0.01% |
+34,439
| New | +$664K |
|
|
FARO
2057
DELISTED
Faro Technologies
FARO
| $664K | ﹤0.01% |
13,187
+66
| +0.5% | +$3.32K |
|
|
JCAP
2058
DELISTED
Jernigan Capital, Inc.
JCAP
| $661K | ﹤0.01% |
+34,540
| New | +$661K |
|
2059
Bally's
BALY
$491M
| $660K | ﹤0.01% |
+25,733
| New | +$660K |
|
2060
Marcus Corp
MCS
$503M
| $659K | ﹤0.01% |
20,758
-977
| -4% | -$31K |
|
2061
Preferred Bank
PFBC
$1.17B
| $658K | ﹤0.01% |
10,954
+4,689
| +75% | +$282K |
|
2062
Alaunos Therapeutics
TCRT
$5.25M
| $658K | ﹤0.01% |
929
+284
| +44% | +$201K |
|
|
NXGN
2063
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $656K | ﹤0.01% |
40,826
+8,636
| +27% | +$139K |
|
2064
Garrett Motion
GTX
$2.69B
| $654K | ﹤0.01% |
65,511
+4,588
| +8% | +$45.8K |
|
2065
Manitowoc
MTW
$363M
| $654K | ﹤0.01% |
37,369
-25
| -0.1% | -$438 |
|
|
HTB
2066
HomeTrust Bancshares, Inc.
HTB
$725M
| $653K | ﹤0.01% |
24,339
+3,106
| +15% | +$83.3K |
|
2067
Vanda Pharmaceuticals
VNDA
$272M
| $652K | ﹤0.01% |
39,743
-4,913
| -11% | -$80.6K |
|
2068
SpartanNash
SPTN
$898M
| $647K | ﹤0.01% |
45,437
+6,214
| +16% | +$88.5K |
|
|
BMTC
2069
DELISTED
Bryn Mawr Bank Corp
BMTC
| $647K | ﹤0.01% |
15,679
+2,222
| +17% | +$91.6K |
|
2070
Encore Capital Group
ECPG
$1.02B
| $645K | ﹤0.01% |
18,249
-6,288
| -26% | -$222K |
|
2071
Ennis
EBF
$473M
| $645K | ﹤0.01% |
29,786
-1,341
| -4% | -$29K |
|
|
PRNB
2072
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
| $645K | ﹤0.01% |
+11,767
| New | +$645K |
|
|
XENT
2073
DELISTED
Intersect ENT, Inc
XENT
| $644K | ﹤0.01% |
25,861
+13,761
| +114% | +$343K |
|
|
EBIX
2074
DELISTED
Ebix Inc
EBIX
| $644K | ﹤0.01% |
19,268
+88
| +0.5% | +$2.94K |
|
2075
Origin Bancorp
OBK
$1.1B
| $642K | ﹤0.01% |
16,978
+10,366
| +157% | +$392K |
|